Clinical trial · Observational
Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc
Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma
NCT05604664CI-TRIAL-00061975completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question\[s\] it aims to answer is: * provide a basis for accurate staging and the relationship between OS and lymph node dissection
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- 5-year survival rate of lymph nodes metastases (%) in patients
- timeFrame
- 2010.1.1-2017.12.30
- description
- Surgical data were retrospectively collected
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0) 2. Underwent esophagecomy (two-field or three-field LN dissection) 3. The primary tumor was thoracic ESCC Exclusion Criteria: 1. Located outside the thoracic 2. Patients underwent salvage or R1/R2 esophagecomy 3. The number of resected lymph nodes (RLNs) less than 15 4. With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)
References
Publications (0)
Data not yet available
No reference posted for this study.